Microbiology of bacterial CAP using traditional and molecular techniques

European Respiratory Monograph

Volumn 63, Issue , 2014, Pages 25-41

  Lung, Mayli ^a,b   Rello, Jordi ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ANAEROBIC CELL CULTURE; ANTIBIOTIC SENSITIVITY; ANTIGEN DETECTION; ARTICLE; BIOLOGICAL WARFARE; BRONCHOSCOPY; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; ENTEROBACTERIACEAE; ENZYME IMMUNOASSAY; GENE SEQUENCE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOFLUORESCENCE TEST; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MICROBIOLOGY; MORAXELLA CATARRHALIS; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOPLASMA PNEUMONIAE; PLEURA EFFUSION; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; SPUTUM CYTODIAGNOSIS; STREPTOCOCCUS PNEUMONIAE; TRACHEAL ASPIRATION PROCEDURE;

EID: 84905739203     PISSN: 1025448X     EISSN: 20756674     Source Type: Book Series    
DOI: 10.1183/1025448x.10003213     Document Type: Article

References (140)

1. Cilloniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax 2011; 66: 340-346.
2. Johansson N, Kalin M, Tiveljung-Lindell A, et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010; 50: 202-209.
3. Saito A, Kohno S, Matsushima T, et al. Prospective multicenter study of the causative organisms of communityacquired pneumonia in adults in Japan. J Infect Chemother 2006; 12: 63-69.
4. Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56: 296-301.
5. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160: 397-405.
6. Howard LS, Sillis M, Pasteur MC, et al. Microbiological profile of community-acquired pneumonia in adults over the last 20 years. J Infect 2005; 50: 107-113.
7. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J2002; 20: Suppl. 36, 20s-27s.
8. File TM. Community-acquired pneumonia. Lancet 2003; 362: 1991-2001.
9. Reissig A, Mempel C, Schumacher U, et al. Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines. Lung 2013; 191: 239-246.
10. Vardakas KZ, Matthaiou DK, Falagas ME. Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. Eur Respir J2009; 34: 1148-1158.
11. Kreienbuehl L, Charbonney E, Eggimann P. Community-acquired necrotizing pneumonia due to methicillinsensitiveStaphylococcus aureussecreting Panton-Valentine leukocidin: a review of case reports. Ann Intensive Care 2011; 1: 52.
12. Cilloniz C, Ewig S, Ferrer M, et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care 2011; 15: R209.
13. von Baum H, Welte T, Marre R, et al. Community-acquired pneumonia throughEnterobacteriaceaeand Pseudomonas aeruginosa: diagnosis, incidence and predictors. Eur Respir J2010; 35: 598-605.
14. Fleming V, Buck B, Nix N, et al. Community-acquired pneumonia with risk for drug-resistant pathogens. South Med J2013; 106: 209-216.
15. Sopena N, Sabria M, Pedro-Botet ML, et al. Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis 1999; 18: 852-858.
16. Carratala J, Garcia-Vidal C. An update onLegionella. Curr Opin Infect Dis 2010; 23: 152-157.
17. Lenglet A, Herrador Z, Magiorakos AP, et al. Surveillance status and recent data forMycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012. Euro Surveill 2012; 17: pii, 20075.
18. Torres A, Rello J. Update in community-acquired and nosocomial pneumonia 2009. Am J Respir Crit Care Med 2010; 181: 782-787.
19. Marrie TJ. Q fever pneumonia. Infect Dis Clin North Am 2010; 24: 27-41.
20. Gacouin A, Revest M, Letheulle J, et al. Distinctive features between community-acquired pneumonia (CAP) due toChlamydophila psittaciand CAP due toLegionella pneumophilaadmitted to the intensive care unit (ICU). Eur J Clin Microbiol Infect Dis 2012; 31: 2713-2718.
21. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27-S72.
22. Gencay M, Roth M, Christ-Crain M, et al. Single and multiple viral infections in lower respiratory tract infection. Respiration 2010; 80: 560-567.
23. de Roux A, Ewig S, Garcia E, et al. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J 2006; 27: 795-800.
24. Cilloniz C, Polverino E, Ewig S, et al. Impact of age and comorbidity on etiology and outcome in communityacquired pneumonia. Chest 2013; 144: 999-1007.
25. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1-iii55.
26. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect 2011; 17: Suppl. 6, E1-59.
27. Ewig S, Schlochtermeier M, Goke N, et al. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 2002; 121: 1486-1492.
28. Manali E, Papadopoulos A, Tsiodras S, et al. The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques. Scand J Infect Dis 2008; 40: 286-292.
29. Hohenthal U, Sipila J, Vainionpaa R, et al. Diagnostic value of bronchoalveolar lavage in community-acquired pneumonia in a routine setting: a study on patients treated in a Finnish university hospital. Scand J Infect Dis 2004; 36: 198-203.
30. Menendez R, Torres A Treatment failure in community-acquired pneumonia, Chest 2007; 132: 1348-1355.
31. Loens K, Van Heirstraeten L, Malhotra-Kumar S, et al. Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections. J Clin Microbiol 2009; 47: 21-31.
32. Resti M, Micheli A, Moriondo M, et al. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection. Clin Ther 2009; 31: 1266-1273.
33. Liu YF, Gao Y, Chen MF, et al. Etiological analysis and predictive diagnostic model building of communityacquired pneumonia in adult outpatients in Beijing, China. BMC Infect Dis 2013; 13: 309.
34. Murray PR, Washington JA. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc 1975; 50: 339-344.
35. Anevlavis S, Petroglou N, Tzavaras A, et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect 2009; 59: 83-89.
36. Roson B, Carratala J, Verdaguer R, et al. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000; 31: 869-874.
37. Miyashita N, Shimizu H, Ouchi K, et al. Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit 2008; 14: CR171-CR176.
38. Fujisaki R, Yamaoka T, Yamamura M, et al. Usefulness of gram-stained sputum obtained just after administration of antimicrobial agents as the earliest therapeutic indicator for evaluating the effectiveness of empiric therapy in community-acquired pneumonia caused by pneumococcus orMoraxella catarrhalis. J Infect Chemother 2013; 19: 517-523.
39. rd Edn. Washington DC, American Society for Microbiology, 2010; pp. 3. 11. 2. 1-3. 11. 2. 20.
40. Bouza E, Torres MV, Burillo A. Aportación del laboratorio de microbiología al diagnóstico de la neumonía asociada a la ventilación mecánica [The contribution of the microbiology laboratory to the diagnosis of ventilator-associated pneumonia]. Enferm Infect Microbiol Clin 2005; 23: Suppl. 3, 2-9.
41. Ruiz M, Torres A, Ewig S, et al. Noninvasiveversusinvasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 2000; 162: 119-125.
42. Rasmussen TR, Korsgaard J, Moller JK, et al. Quantitative culture of bronchoalveolar lavage fluid in communityacquired lower respiratory tract infections. Respir Med 2001; 95: 885-890.
43. Yamasaki K, Kawanami T, Yatera K, et al. Significance of anaerobes and oral bacteria in community-acquired pneumonia. PLoS One 2013; 8: e63103.
44. Joseph CA, Ricketts KD. Legionnaires disease in Europe 2007-2008. Euro Surveill 2010; 15: 19493.
45. Lamoth F, Greub G. Fastidious intracellular bacteria as causal agents of community-acquired pneumonia. Expert Rev Anti Infect Ther 2010; 8: 775-790.
46. Blyth CC, Adams DN, Chen SC. Diagnostic and typing methods for investigatingLegionellainfection. NSW Public Health Bull 2009; 20: 157-161.
47. Murdoch DR. Diagnosis ofLegionellainfection. Clin Infect Dis 2003; 36: 64-69.
48. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001; 95: 78-82.
49. Bishara J, Leibovici L, Ashkenazi S, et al. Seven-year study of bacteraemic pneumonia in a single institution. Eur J Clin Microbiol Infect Dis 2000; 19: 926-931.
50. Ishikawa G, Nishimura N, Kitamura A, et al. Impact of blood cultures on the changes of treatment in hospitalised patients with community-acquired pneumonia. Open Respir Med J2013; 7: 60-66.
51. Marrie TJ. Blood cultures in ambulatory patients who are discharged from emergency with community-acquired pneumonia. Can J Infect Dis 2004; 15: 21-24.
52. Jacobs JA, Stobberingh EE, Cornelissen EI, et al. Detection ofStreptococcus pneumoniaeantigen in bronchoalveolar lavage fluid samples by a rapid immunochromatographic membrane assay. J Clin Microbiol 2005; 43: 4037-4040.
53. Dominguez J, Andreo F, Blanco S, et al. Rapid detection of pneumococcal antigen in serum samples for diagnosing pneumococcal pneumonia. J Infect 2006; 53: 21-24.
54. Genne D, Siegrist HH, Lienhard R. Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Binax NOW). Int J Infect Dis 2006; 10: 124-128.
55. Muder RR, Yu VL. Infection due toLegionellaspecies other thanL. pneumophila. Clin Infect Dis 2002; 35: 990-998.
56. Ruf B, Schurmann D, Horbach I, et al. Prevalence and diagnosis ofLegionella pneumonia: a 3-year prospective study with emphasis on application of urinary antigen detection. J Infect Dis 1990; 162: 1341-1348.
57. Dominguez J, Gali N, Matas L, et al. Evaluation of a rapid immunochromatographic assay for the detection of Legionellaantigen in urine samples. Eur J Clin Microbiol Infect Dis 1999; 18: 896-898.
58. Munoz MJ, Martinez Toldos MC, Yague G, et al. Evaluation of three immunochromatographic assays for detection ofLegionella pneumophilaserogroup 1 antigen in urine samples. Rev Esp Quimioter 2009; 22: 207-209.
59. Helbig JH, Uldum SA, Luck PC, et al. Detection ofLegionella pneumophilaantigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both BinaxLegionellaUrinary Enzyme Immunoassay (EIA) and Biotest LegionellaUrin Antigen EIA. J Med Microbiol 2001; 50: 509-516.
60. Bruin JP, Diederen BM. Evaluation of Meridian TRU Legionella1, a new rapid test for detection of Legionella pneumophilaserogroup 1 antigen in urine samples. Eur J Clin Microbiol Infect Dis 2013; 32: 333-334.
61. Diederen BM, Peeters MF. Evaluation of two new immunochromatographic assays (Rapid ULegionellaantigen test and SD BiolineLegionellaantigen test) for detection ofLegionellapneumophila serogroup 1 antigen in urine. J Clin Microbiol 2006; 44: 2991-2993.
62. Held J. Increasing the sensitivity of the BinaxNOW Legionella urinary antigen immunochromatographic test by additional readings at later time points. J Med Microbiol 2012; 61: 884-885.
63. Shimada T, Noguchi Y, Jackson JL, et al. Systematic review and metaanalysis: urinary antigen tests for Legionellosis. Chest 2009; 136: 1576-1585.
64. Boersma WG, Lowenberg A, Holloway Y, et al. Pneumococcal capsular antigen detection and pneumococcal serology in patients with community acquired pneumonia. Thorax 1991; 46: 902-906.
65. Cerosaletti KM, Roghmann MC, Bentley DW Comparison of latex agglutination, counter immunoelectrophoresis for the detection of pneumococcal antigen in elderly pneumonia patients. J Clin Microbiol 1985; 22: 553-557.
66. Ericsson CH, Hallander HO, Rosen A, et al. Routine use of counterimmunoelectrophoresis for the detection of pneumococcal antigen in sputum. Med Microbiol Immunol 1986; 175: 241-249.
67. Dominguez J, Gali N, Blanco S, et al. Detection ofStreptococcus pneumoniaeantigen by a rapid immunochromatographic assay in urine samples. Chest 2001; 119: 243-249.
68. Murdoch DR, Laing RT, Mills GD, et al. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniaeantigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol 2001; 39: 3495-3498.
69. Roson B, Fernandez-Sabe N, Carratala J, et al. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis 2004; 38: 222-226.
70. Ishida T, Hashimoto T, Arita M, et al. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniaein community-acquired pneumonia: utility and clinical impact on the reported etiology. J Infect Chemother 2004; 10: 359-363.
71. Gutierrez F, Masia M, Rodriguez JC, et al. Evaluation of the immunochromatographic Binax NOW assay for detection ofStreptococcus pneumoniaeurinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis 2003; 36: 286-292.
72. Sinclair A, Xie X, Teltscher M, et al. Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused byStreptococcus pneumoniae. J Clin Microbiol 2013; 51: 2303-2310.
73. Tzeng DH, Lee YL, Lin YH, et al. Diagnostic value of the Binax NOW assay for identifying a pneumococcal etiology in patients with respiratory tract infection. J Microbiol Immunol Infect 2006; 39: 39-44.
74. Dowell SF, Garman RL, Liu G, et al. Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among paediatric patients. Clin Infect Dis 2001; 32: 824-825.
75. Porcel JM, Ruiz-Gonzalez A, Falguera M, et al. Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia. Chest 2007; 131: 1442-1447.
76. Marcos MA, Jimenez de Anta MT, de la Bellacasa JP et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J2003; 21: 209-214.
77. Huijts SM, Pride MW, Vos JM, et al. Diagnostic accuracy of a serotype specific antigen test in communityacquired pneumonia. Eur Respir J2013; 42: 1283-1290.
78. Tenover FC. Developing molecular amplification methods for rapid diagnosis of respiratory tract infections caused by bacterial pathogens. Clin Infect Dis 2011; 52: Suppl. 4, S338-S345.
79. Azzari C, Moriondo M, Indolfi G, et al. Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease byStreptococcus pneumoniaein Italian children. J Med Microbiol 2008; 57: 1205-1212.
80. Abu Raya B, Bamberger E, Gershtein R, et al. The laboratory diagnosis ofBordetella pertussisinfection: a comparison of semi-nested PCR and real-time PCR with culture. Eur J Clin Microbiol Infect Dis 2012; 31: 619-622.
81. Jernigan DB, Lindstrom SL, Johnson JR, et al. Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis 2011; 52: Suppl. 1, S36-S43.
82. Caliendo AM. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin Infect Dis 2011; 52: Suppl. 4, S326-S330.
83. Endimiani A, Hujer KM, Hujer AM, et al. Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?Clin Infect Dis 2011; 52: Suppl. 4, S373-S383.
84. Wolk DM, Struelens MJ, Pancholi P, et al. Rapid detection ofStaphylococcus aureusand methicillin-resistantS. aureus(MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol 2009; 47: 823-826.
85. Wolk DM, Picton E, Johnson D, et al. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus(MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol 2009; 47: 758-764.
86. Cercenado E, Marin M, Burillo A, et al. Rapid detection ofStaphylococcus aureusin lower respiratory tract secretions from patients with suspected ventilator-associated pneumonia: evaluation of the Cepheid Xpert MRSA/SA SSTI assay. J Clin Microbiol 2012; 50: 4095-4097.
87. Poritz MA, Blaschke AJ, Byington CL, et al. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One 2011; 6: e26047.
88. Popowitch EB, O'Neill SS, Miller MB. Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP fast multiplex assays for detection of respiratory viruses. J Clin Microbiol 2013; 51: 1528-1533.
89. Seiner DR, Colburn HA, Baird C, et al. Evaluation of the FilmArray1system for detection ofBacillus anthracis, Francisella tularensisandYersinia pestis. J Appl Microbiol 2013; 114: 992-1000.
90. Blaschke AJ, Heyrend C, Byington CL, et al. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis 2012; 74: 349-355.
91. Van Wesenbeeck L, Meeuws H, Van Immerseel A, et al. Comparison of the FilmArray RP, Verigene RV+, and Prodesse ProFLU+/FAST+multiplex platforms for detection of influenza viruses in clinical samples from the 2011-2012 influenza season in Belgium. J Clin Microbiol 2013; 51: 2977-2985.
92. Hayden RT, Gu Z, Rodriguez A, et al. Comparison of two broadly multiplexed PCR systems for viral detection in clinical respiratory tract specimens from immunocompromised children. J Clin Virol 2012; 53: 308-313.
93. Rand KH, Rampersaud H, Houck HJ. Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVP. J Clin Microbiol 2011; 49: 2449-2453.
94. Loeffelholz MJ, Pong DL, Pyles RB, et al. Comparison of the FilmArray Respiratory Panel and Prodesse real-time PCR assays for detection of respiratory pathogens. J Clin Microbiol 2011; 49: 4083-4088.
95. Klein M, Barth S, Burrack-Lange S, et al. First clinical validation of a rapid molecular test the Unyvero TM P50 Pneumonia Application detecting microorganisms and antibiotic resistance in patients with suspected severe pneumonia. ECCMID 2013, poster P1781.
96. Mackay IM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect 2004; 10: 190-212.
97. Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006; 19: 165-256.
98. Werno AM, Anderson TP, Murdoch DR Association between pneumococcal load, disease severity in adults with pneumonia. J Med Microbiol 2012; 61: 1129-1135.
99. Rello J, Lisboa T, Lujan M, et al. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009; 136: 832-840.
100. Johansson N, Kalin M, Giske CG, et al. Quantitative detection ofStreptococcus pneumoniaefrom sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis 2008; 60: 255-261.
101. Abdeldaim GM, Stralin K, Olcen P, et al. QuantitativefucK gene polymerase chain reaction on sputum and nasopharyngeal secretions to detectHaemophilus influenzaepneumonia. Diagn Microbiol Infect Dis 2013; 76: 141-146.
102. Maurin M, Hammer L, Gestin B, et al. Quantitative real-time PCR tests for diagnostic and prognostic purposes in cases of legionellosis. Clin Microbiol Infect 2010; 16: 379-384.
103. Welti M, Jaton K, Altwegg M, et al. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophilaandMycoplasma pneumoniaein respiratory tract secretions. Diagn Microbiol Infect Dis 2003; 45: 85-95.
104. Albrich WC, Madhi SA, Adrian PV, et al. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis 2012; 54: 601-609.
105. Sethi S. Molecular diagnosis of respiratory tract infection in acute exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis 2011; 52: Suppl. 4, S290-S295.
106. Curran T, Coyle PV, McManus TE, et al. Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease. FEMS Immunol Med Microbiol 2007; 50: 112-118.
107. Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax 2012; 67: 1075-1080.
108. Rappe MS, Giovannoni SJ. The uncultured microbial majority. Annu Rev Microbiol 2003; 57: 369-394.
109. Rampini SK, Bloemberg GV, Keller PM, et al. Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections. Clin Infect Dis 2011; 53: 1245-1251.
110. Sontakke S, Cadenas MB, Maggi RG, et al. Use of broad range16S rDNA PCR in clinical microbiology. J Microbiol Methods 2009; 76: 217-225.
111. Rogers GB, Carroll MP, Bruce KD. Studying bacterial infections through culture-independent approaches. J Med Microbiol 2009; 58: 1401-1418.
112. Harris KA, Hartley JC. Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service. J Med Microbiol 2003; 52: 685-691.
113. rd. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 2004; 17: 840-862.
114. Patel JB. 16S rRNA gene sequencing for bacterial pathogen identification in the clinical laboratory. Mol Diagn 2001; 6: 313-321.
115. Kotilainen P, Jalava J, Meurman O, et al. Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluid. J Clin Microbiol 1998; 36: 2205-2209.
116. Arosio M, Nozza F, Rizzi M, et al. Evaluation of the MicroSeq 500 16S rDNA-based gene sequencing for the diagnosis of culture-negative bacterial meningitis. New Microbiol 2008; 31: 343-349.
117. Marin M, Munoz P, Sanchez M, et al. Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore)2007; 86: 195-202.
118. Vandercam B, Jeumont S, Cornu O, et al. Amplification-based DNA analysis in the diagnosis of prosthetic joint infection. J Mol Diagn 2008; 10: 537-543.
119. Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174: 817-823.
120. Jenkins C, Ling CL, Ciesielczuk HL, et al. Detection and identification of bacteria in clinical samples by 16S rRNA gene sequencing: comparison of two different approaches in clinical practice. J Med Microbiol 2012; 61: 483-488.
121. Hernes SS, Hagen E, Tofteland S, et al. Transthoracic fine-needle aspiration in the aetiological diagnosis of community-acquired pneumonia. Clin Microbiol Infect 2010; 16: 909-911.
122. Diederen BM, van Zwet AA, van der Zee A, et al. Community-acquired pneumonia caused byLegionella longbeachae in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 2005; 24: 545-548.
123. Dorbecker C, Licht C, Korber F, et al. Community-acquired pneumonia due toBordetella holmesiiin a patient with frequently relapsing nephrotic syndrome. J Infect 2007; 54: e203-205.
124. Martinez MA, Ruiz M, Zunino E, et al. Detection ofMycoplasma pneumoniaein adult community-acquired pneumonia by PCR and serology. J Med Microbiol 2008; 57: 1491-1495.
125. Haider S, Collingro A, Walochnik J, et al. Chlamydia-like bacteria in respiratory samples of community-acquired pneumonia patients. FEMS Microbiol Lett 2008; 281: 198-202.
126. Keller PM, Rampini SK, Buchler AC, et al. Recognition of potentially novel human disease-associated pathogens by implementation of systematic 16S rRNA gene sequencing in the diagnostic laboratory. J Clin Microbiol 2010; 48: 3397-3402.
127. Kommedal O, Kvello K, Skjastad R, et al. Direct 16S rRNA gene sequencing from clinical specimens, with special focus on polybacterial samples and interpretation of mixed DNA chromatograms. J Clin Microbiol 2009; 47: 3562-3568.
128. Miyashita N, Fukano H, Mouri K, et al. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalised patient study. J Med Microbiol 2005; 54: 395-400.
129. Mosammaparast N, McAdam AJ, Nolte FS. Molecular testing for infectious diseases should be done in the clinical microbiology laboratory. J Clin Microbiol 2012; 50: 1836-1840.
130. Boudewijns M, Bakkers JM, Sturm PD, et al. 16S rRNA gene sequencing and the routine clinical microbiology laboratory: a perfect marriage?J Clin Microbiol 2006; 44: 3469-3470.
131. Fournier PE, Raoult D. Prospects for the future using genomics and proteomics in clinical microbiology. Annu Rev Microbiol 2011; 65: 169-188.
132. Hugenholtz P, Tyson GW. Microbiology: metagenomics. Nature 2008; 455: 481-483.
133. Cox MJ, Cookson WO, Moffatt MF. Sequencing the human microbiome in health and disease. Hum Mol Genet 2013; 22: R88-94.
134. Salipante SJ, Sengupta DJ, Rosenthal C, et al. Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS One 2013; 8: e65226.
135. Sundquist A, Bigdeli S, Jalili R, et al. Bacterial flora-typing with targeted, chip-based Pyrosequencing. BMC Microbiol 2007; 7: 108.
136. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359.
137. Cabrera-Rubio R, Garcia-Nunez M, Seto L, et al. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J Clin Microbiol 2012; 50: 3562-3568.
138. Conrad D, Haynes M, Salamon P, et al. Cystic fibrosis therapy: a community ecology perspective. Am J Respir Cell Mol Biol 2013; 48: 150-156.
139. Pallen MJ, Loman NJ, Penn CW. High-throughput sequencing and clinical microbiology: progress, opportunities and challenges. Curr Opin Microbiol 2010; 13: 625-631.
140. Armougom F, Bittar F, Stremler N, et al. Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing. Eur J Clin Microbiol Infect Dis 2009; 28: 1151-1154.